[GnRH antagonist].
Yano
T
T
Department of Obstetrics and Gynecology, Faculty of Medicine, University of Tokyo.
Taketani
Y
Y
D000818:Animals; D004195:Disease Models, Animal; D016889:Endometrial Neoplasms / Q000188:drug therapy; D004715:Endometriosis / Q000188:drug therapy*; D005260:Female; D007987:Gonadotropin-Releasing Hormone / Q000031:analogs & derivatives* / Q000037:antagonists & inhibitors* / Q000494:pharmacology / Q000627:therapeutic use; D006727:Hormone Antagonists / Q000494:pharmacology / Q000627:therapeutic use; D006801:Humans; D007889:Leiomyoma / Q000188:drug therapy; D007986:Luteinizing Hormone / Q000097:blood; D008297:Male; D010051:Ovarian Neoplasms / Q000188:drug therapy; D011966:Receptors, LHRH / Q000378:metabolism; D013739:Testosterone / Q000097:blood; D014594:Uterine Neoplasms / Q000188:drug therapy
D006727:Hormone Antagonists; D011966:Receptors, LHRH; D007987:Gonadotropin-Releasing Hormone; D013739:Testosterone; D007986:Luteinizing Hormone; C062876:cetrorelix